drugset / Trial / NCT02273518
Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
Comparative pharmacokinetics of dipyridamole in two new formulations of Asasantin ER compared to the present commercial formulation
Timeline
- Start
- 2001-04
- Primary completion
- 2001-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASA | Unknown | 25 mg | — |
| Subject | Dipyridamole | Other / unclassified | 200 mg | — |
Indications
No indication recorded.